/Spikenard
[search]
 SomaLibrary
 signin

Spikenard

Spikenard

Introduction

In Ancient Greek Texts

⚠️ TODO: fill some example source texts from ancient/classical authors here...

Nard (often rendered “spikenard” in later English) belongs to the high-prestige aromatic category: imported, costly, and used in perfumery and medicine. This is exactly the kind of plant-product that Greek writers treat under aromatics - and it appears as such in the Dioscoridean tradition of cataloging scent materials and their applications.

While a lot of popular writing about nard is later and devotional, Greek pharmacological literature in the Roman-era period explicitly inventories nard among aromatics and differentiates kinds/regions, indicating it was not merely poetic but a real commodity in the perfumer-pharmacist world.

In the biblical texts

Spikenard — also known as nard or muskroot — is one of the few medicinal plants mentioned by name in the Greek New Testament. Like many botanicals in the biblical narratives, however, it appears primarily as a perfume or sacred aromatic rather than something consumed. Its effects would therefore have been delivered through inhalation of fragrance or through absorption in anointing oils, not through ingestion.

  • In Mark 14:3, a woman pours costly nard oil over Jesus’ head in the house of Simon the Leper, and
  • in John 12:3, Mary anoints his feet with the same substance. See also Feet as Euphemism for Genitals.

In both accounts, nard functions as a potent, aromatic oil with ritual and possibly protective significance.

Botanically, spikenard is related to valerian, a plant long associated with calming (anti-anxiety anti-stress) properties. While spikenard itself has not been studied as extensively as valerian root, early experimental research suggests it may possess anxiolytic, anti-inflammatory, and antibacterial properties. In that sense, its use in ancient ritual and medicinal contexts aligns with what modern pharmacology tentatively indicates about the plant’s bioactive profile.

See Also